This programme in the Ross Fund Portfolio (which focusses on neglected tropical diseases, diseases of emerging resistance and diseases of epidemic potential) will support the development of new products (such as drugs, diagnostics and insecticides) for targeted diseases, including diseases of emerging resistance (that are becoming an increasing threat globally); neglected tropical diseases (that affect over a billion people worldwide); and diseases of epidemic potential (that can rapidly spread if not stopped).
To provide increased coverage with essential reproductive, maternal and child health services in DFID-supported health zones. To increase coverage with essential health services in 52 DFID-supported health zones in five provinces (Nord Ubangi, Kasai-Centrale, Kasai, Maniema, Tshopo). This will benefit over 9 million Congolese citizens, and contributes towards achievement of MDGs through the delivery of services to improve reproductive, maternal and child health
To improve maternal and newborn child health in Northern Nigeria through increased skilled birth attendance, antenatal care attendance, immunisation rates, newborns receiving low-cost, live-saving interventions, and pregnant women and children protected from vaccine-preventable diseases. This will save the lives of 60,000 children, 42,000 newborns and 2,000 pregnant women in the six programme states; and provide 6.3 million high quality MNCH services to women and children of Northern Nigeria. This contributes toward MDG 4 and 5 by reducing maternal and child mortality; improve health system coordination through health sector planning and financing and improve demand for and access to high quality health services by 2019.”
1) Deliver the UK's ambition to be internationally outstanding in global health research, improving the lives of people in LMICs. 2) Create an environment where world-class global health research, focused on the needs of LMICs can thrive. 3) Translate advances in applied global health research into benefits for patients and the public in LMICs. 4) Focus on priority areas which will have the greatest impact on health in LMICs in the short, medium and long term. 5) Provide high quality research evidence to inform decision-making by public health officials, practitioners and policy makers. 6) Increase the volume and quality of multi-disciplinary global health research from the UK. 7) Develop knowledge and capacity within existing UK institutions which can be translated into global health research practice. 8) Retain a level of responsive research capacity to address emerging global health research requirements (Units only).
Results-Based Financing (RBF) approaches implemented by partners as a key mechanism to improve the demand for and utilisation of health services, especially by pregnant women and children. Increase the volume and quality of cost effective basic health services, especially maternal and child health services
To scale-up water, sanitation and hygiene coverage in Nigeria by providing 4.68 million new beneficiaries plus continued support to 2.32 million covered under Phase 1, with access to appropriate and safe sanitation facilities, hygiene education activities and a sustainable safe and reliable water supply to reduce exposure to public health risks and disease transmission. This contributes to our Millennium Development Goals (MDGs) by helping to sustain and embed improved sanitation, water and hygiene practices. Phase 2 of the Sanitation, Hygiene and Water in Nigeria Programme (SHAWN) will benefit 7 million people in total, in six northern states in Nigeria by December 2018.
Improve the health of Somalis which leads to improved human development and economic development outcomes for Somalia.
To improve the health of women, children, the poor and socially excluded in Nepal, including by restoring health services in areas affected by the 2015 earthquake, and improving the quality and governance of health services nationwide.
To generate new knowledge that promises to contribute to improvement of health in developing countries. The programme will give priority to proposals that are most likely to produce implementable results and are designed to address the major causes of mortality or morbidity in developing countries.
To support a resilient health system in Zimbabwe that is equipped to deliver quality sexual, reproductive, maternal, newborn, child and adolescent health and nutrition services. In total the programme will benefit 5.4 million women and children in Zimbabwe and help save over 13,000 lives.